{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:18:55Z","timestamp":1788812335012,"version":"build-2803163510"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The Optilume benign prostatic hyperplasia (BPH) catheter system is a novel minimally invasive paclitaxel-coated dilation system that has demonstrated substantial and durable results in urinary flow and symptoms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>We now assess the impact of Optilume BPH procedure on sexual function.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Prior published results have described the methods of data collection during the PINNACLE study, which demonstrated durable improvement in urinary symptoms. Follow-up assessments for the current study included IIEF-EF and Male Sexual Health Questionnaire for Ejaculatory Dysfunction (MSHQ-EjD). Semen quality was also examined.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>IIEF-EF and MSHQ-EjD scores in the Optilume BPH group were not different from the sham group at 3\u00a0months, 6\u00a0months, or 12\u00a0months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 148 men were randomized to receive the procedure (100) or a sham surgical procedure (48). Subjects in both groups had similar rates of erectile dysfunction (ED) previously diagnosed at baseline (56% vs 54.2%, P = .83) and those men who were sexually active. IIEF-EF and MSHQ-EjD scores in the Optilume BPH group were not different from the sham group at 3, 6, or 12\u00a0months. Change in IIEF-EF scores remained consistent across all levels of baseline ED severity after Optilume BPH procedure. No clear trend was seen after treatment with Optilume BPH for semen volume, sperm motility, progressive motility, or sperm morphology.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Implications<\/jats:title>\n                  <jats:p>The Optilume BPH catheter system provides patients with a durable improvement in lower urinary tract symptoms while preserving sexual function.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths and limitations<\/jats:title>\n                  <jats:p>This study uses validated questionnaires to assess patients\u2019 sexual function at baseline and regularly for 1\u00a0year after the procedure. Given exclusion criteria regarding patient age and prostate size, the results may not be applicable to all BPH phenotypes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Optilume appears to provide clinical benefit with a high degree of patient satisfaction and minimal impact on sexual function.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jsxmed\/qdae206","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T08:12:29Z","timestamp":1737360749000},"page":"446-453","source":"Crossref","is-referenced-by-count":12,"title":["Preservation of sexual function with Optilume\u2014a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5157-5655","authenticated-orcid":false,"given":"Olivia","family":"Copelan","sequence":"first","affiliation":[{"name":"The Center for Men\u2019s Health Stritch School of Medicine , Maywood, IL 60153 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Moss","sequence":"additional","affiliation":[{"name":"Oschner LSU Health , Shreveport, LA 60153 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon","family":"Freedman","sequence":"additional","affiliation":[{"name":"Sheldon Freedman Urology , Las Vegas, NV 60153 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Coutinho","sequence":"additional","affiliation":[{"name":"New Jersey Urology LLC, Millburn , NJ 60153 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Elterman","sequence":"additional","affiliation":[{"name":"University of Toronto , Toronto, ON 60153 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Marotte","sequence":"additional","affiliation":[{"name":"Arkansas Urology , Little Rock, AR 60153 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo","family":"Padron","sequence":"additional","affiliation":[{"name":"Florida Urology Partners , Tampa, FL 60153 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Shore","sequence":"additional","affiliation":[{"name":"Carolina Urologic Research Center , Myrtle Beach, SC 60153 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Spier","sequence":"additional","affiliation":[{"name":"Rio Grande Urology , El Paso, TX 60153 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jed","family":"Kaminetsky","sequence":"additional","affiliation":[{"name":"Manhattan Medical Research Center , New York, NY 60153 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Mazzarella","sequence":"additional","affiliation":[{"name":"Urology Austin , Austin, TX 60153 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Te","sequence":"additional","affiliation":[{"name":"Weill Medical College of Cornell University , New York, NY 60153 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Mount Sinai Health System , New York, NY 60153 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin T","family":"McVary","sequence":"additional","affiliation":[{"name":"The Center for Men\u2019s Health Stritch School of Medicine , Maywood, IL 60153 ,","place":["United States"]},{"name":"Department of Urology , Stritch School of Medicine, Loyola University Medical University, Maywood, IL 60153,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,19]]},"reference":[{"issue":"4","key":"2025041108411779700_ref1","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/JU.0000000000002183","article-title":"Management of Lower Urinary Tract Symptoms Attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I-initial work-up and medical management","volume":"206","author":"Lerner","year":"2021","journal-title":"J Urol"},{"issue":"6","key":"2025041108411779700_ref2","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.eururo.2003.08.015","article-title":"Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7)","volume":"44","author":"Rosen","year":"2003","journal-title":"Eur Urol"},{"issue":"3","key":"2025041108411779700_ref3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1185\/030079908X260916","article-title":"Identifying patients with benign prostatic hyperplasia through a diagnosis of, or treatment for, erectile dysfunction","volume":"24","author":"McVary","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"2025041108411779700_ref4","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.urology.2015.04.054","article-title":"The Co-occurring syndrome-coexisting erectile dysfunction and benign prostatic hyperplasia and their clinical correlates in aging men: results from the National Health and nutrition examination survey","volume":"86","author":"Egan","year":"2015","journal-title":"Urology"},{"issue":"6","key":"2025041108411779700_ref5","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.juro.2013.12.014","article-title":"Change in sexual function in men with lower urinary tract symptoms\/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy","volume":"191","author":"Fwu","year":"2014","journal-title":"J Urol"},{"issue":"10","key":"2025041108411779700_ref6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11934-014-0441-2","article-title":"Impact of alpha blockers, 5-alpha reductase inhibitors and combination therapy on sexual function","volume":"15","author":"Welliver","year":"2014","journal-title":"Curr Urol Rep"},{"issue":"3","key":"2025041108411779700_ref7","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.eururo.2014.11.006","article-title":"Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study","volume":"68","author":"Cindolo","year":"2015","journal-title":"Eur Urol"},{"issue":"6","key":"2025041108411779700_ref8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00345-004-0449-1","article-title":"Erectile dysfunction after transurethral resection of the prostate: incidence and risk factors","volume":"22","author":"Taher","year":"2004","journal-title":"World J Urol"},{"issue":"4","key":"2025041108411779700_ref9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/JU.0000000000001298","article-title":"Surgical Management of Lower Urinary Tract Symptoms Attributed to benign prostatic hyperplasia: AUA Guideline amendment 2020","volume":"204","author":"Parsons","year":"2020","journal-title":"J Urol"},{"issue":"Suppl 4","key":"2025041108411779700_ref10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1464-410X.2005.05486.x","article-title":"Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function","volume":"95","author":"Lowe","year":"2005","journal-title":"BJU Int"},{"issue":"4","key":"2025041108411779700_ref11","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/s41391-021-00362-z","article-title":"One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia","volume":"24","author":"Kaplan","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"2025041108411779700_ref12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/JU.0000000000003568","article-title":"The PINNACLE study: a double-blind, randomized, sham-controlled study evaluating the Optilume BPH catheter system for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"210","author":"Kaplan","year":"2023","journal-title":"J Urol"},{"issue":"6","key":"2025041108411779700_ref13","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"issue":"5","key":"2025041108411779700_ref14","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.urology.2007.02.036","article-title":"Development and validation of four-item version of male sexual health questionnaire to assess ejaculatory dysfunction","volume":"69","author":"Rosen","year":"2007","journal-title":"Urology"},{"issue":"4","key":"2025041108411779700_ref15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.urology.2004.04.056","article-title":"Male sexual health questionnaire (MSHQ): scale development and psychometric validation","volume":"64","author":"Rosen","year":"2004","journal-title":"Urology"},{"issue":"Suppl 2","key":"2025041108411779700_ref16","first-page":"36","article-title":"Advantages of strict (Tygerberg) criteria for evaluation of sperm morphology","volume":"18","author":"Menkveld","year":"1995","journal-title":"Int J Androl"},{"key":"2025041108411779700_ref17","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"2025041108411779700_ref18","volume-title":"WHO Laboratory Manual for the Examination and Processing of Human Semen","year":"2021","edition":"6th"},{"issue":"2","key":"2025041108411779700_ref19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2605.1991.tb01071.x","article-title":"Variation of semen quality in normal men","volume":"14","author":"Mallidis","year":"1991","journal-title":"Int J Androl"},{"issue":"4","key":"2025041108411779700_ref20","first-page":"e184","article-title":"Fertility and the aging male","volume":"13","author":"Harris","year":"2011","journal-title":"Rev Urol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/22\/3\/446\/61503716\/qdae206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/22\/3\/446\/61503716\/qdae206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T08:41:27Z","timestamp":1744360887000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/22\/3\/446\/7961465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,19]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,1,19]]},"published-print":{"date-parts":[[2025,4,8]]}},"URL":"https:\/\/doi.org\/10.1093\/jsxmed\/qdae206","relation":{},"ISSN":["1743-6095","1743-6109"],"issn-type":[{"value":"1743-6095","type":"print"},{"value":"1743-6109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,1,19]]}}}